profit from every $100 of sales.
$0$100
Rapid Micro Biosystems
$0.65-2.98% today
-85.4% in 1 year
1-year low $0.621-year high $4.68
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Rapid Micro Biosystems sold, what it kept, and what it did with the cash.
Sales went from $17.1 million in 2022 to $33.6 million in 2025, with -$47.1 million of profit last year.
SalesProfit
Rapid Micro Biosystems vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Rapid Micro Biosystems | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Rapid Micro Biosystems's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 17 | 23 | 28 | 34 | |
| -9 | -5 | -0 | 1 | |
| -63 | -57 | -50 | -47 | |
| -60 | -53 | -43 | -43 | |
| -61 | -52 | -47 | -47 | |
| -1.43 | -1.22 | -1.08 | -1.05 | |
| -49.8% | -24.4% | -0.4% | 3.1% | |
| -369.0% | -251.2% | -178.0% | -141.1% | |
| -354.9% | -233.0% | -167.2% | -140.3% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 191 | 143 | 98 | 75 |
| Cash | 27 | 24 | 17 | 20 |
| Total debt | 8 | 7 | 6 | 24 |
| Total liabilities | 26 | 25 | 23 | 42 |
| 164 | 118 | 75 | 33 | |
| 42 | 43 | 44 | 45 | |
| -29.0% | -35.7% | -45.4% | -63.7% | |
| -37.0% | -44.5% | -62.2% | -141.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -59 | -45 | -44 | -31 | |
| 7 | 2 | 1 | 1 | |
| -65 | -47 | -46 | -32 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 4 | 5 | 4 | 4 |
Valuation
- –
- –
- –
- 3.4×
- 1.0×
- –
- –
- -97.7%
- -144.3%
- 0.0%
Profitability
- 3.1%
- -141.1%
- -140.3%
- -131.4%
- -82.2%
- -50.1%
- -95.4%
- -63.0%
- -84.1%
- 40.5%
Growth
- +25.2%
- –
- +29.9%
- –
- +1.9%
Financial health
- –
- 0.72
- 31.9%
- -38.7×
- 3.31
- 2.36
- 0.45
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 1%of 952
Bottom 2%of 884
Top 21%of 886
Bottom 1%of 987
What analysts expect
- Average price target
- $8.00
- Range
- $8.00 – $8.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 13, 2026 | -0.31 | -0.25 | −24.0% |
| Mar 12, 2026 | -0.28 | -0.23 | −21.7% |
| Nov 7, 2025 | -0.26 | -0.26 | +0.0% |
| Aug 12, 2025 | -0.27 | -0.26 | −3.8% |
| May 9, 2025 | -0.26 | -0.27 | +3.7% |
| Feb 28, 2025 | -0.22 | -0.22 | +0.0% |
| Nov 1, 2024 | -0.26 | -0.26 | +0.0% |
| Aug 2, 2024 | -0.29 | -0.28 | −3.6% |
News
AOI Sales Up 127%, Gross Margin Stuck at 28%: Rapid Earnings ReactionYahoo Finance · Nov 6, 2026AWS Jumps 39% as Amazon's Cash Flow Sinks: Rapid Earnings ReactionYahoo Finance · Oct 29, 2026Sprouts Guides to Steeper Store Sales Drop: Rapid Earnings ReactionYahoo Finance · Oct 29, 2026Shell Profit Leans on Record Refining Margins: Rapid Earnings ReactionYahoo Finance · Oct 29, 2026Caterpillar Sales Up 17%, Margin Hits 20.4%: Rapid Earnings ReactionYahoo Finance · Oct 29, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
27No pass
Benjamin Graham
38No pass
Philip Fisher
36No pass
Peter Lynch
65Pass
Joel Greenblatt
0No pass
Charlie Munger
21No pass
Terry Smith
28No pass
Questions about Rapid Micro Biosystems
Is Rapid Micro Biosystems a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Rapid Micro Biosystems AI analysis
What does Rapid Micro Biosystems do?
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. It is in Medical - Devices.
Does Rapid Micro Biosystems pay a dividend?
No. Rapid Micro Biosystems does not pay a dividend at the moment.
Is Rapid Micro Biosystems stock halal?
No. Rapid Micro Biosystems does not pass our halal screen: its debt is 73% of its market value, at or above the 33% limit. How we check
How has Rapid Micro Biosystems stock done over the past year?
Down 85.4% over the past twelve months, to $0.65. It traded between $0.62 and $4.68 and is 86.1% below its high.
Who are Rapid Micro Biosystems's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Rapid Micro Biosystems's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.